Patents Assigned to Cerepeut, Inc.
  • Quinazolinone compounds
    Patent number: 12454514
    Abstract: New quinazolinone compounds are disclosed, as well as pharmaceutical compositions containing quinazolinones and methods for the treatment of diseases and conditions associated with mitochondrial dysfunction.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: October 28, 2025
    Assignee: Cerepeut, Inc.
    Inventor: Bingwei Lu
  • Small molecule compound
    Patent number: 12404251
    Abstract: The present invention relates to compositions and methods for the treatment of cancer and other diseases associated with mitochondrial dysfunction, including but not limited to, neurodegenerative disease, brain injuries, and certain non-neurological disorders, using a novel compound, 6-chloro-3-(2,4-dichloro-5-methoxyphenyl)-2-mercapto-7-methoxyquinazolin-4(3H)-one, and derivatives thereof.
    Type: Grant
    Filed: February 26, 2024
    Date of Patent: September 2, 2025
    Assignee: Cerepeut, Inc.
    Inventor: Bingwei Lu
  • NOVEL SMALL MOLECULE COMPOUND
    Publication number: 20240246919
    Abstract: The present invention relates to compositions and methods for the treatment of cancer and other diseases associated with mitochondrial dysfunction, including but not limited to, neurodegenerative disease, brain injuries, and certain non-neurological disorders, using a novel compound, 6-chloro-3-(2,4-dichloro-5-methoxyphenyl)-2-mercapto-7-methoxyquinazolin-4(3H)-one, and derivatives thereof.
    Type: Application
    Filed: February 26, 2024
    Publication date: July 25, 2024
    Applicant: Cerepeut, Inc.
    Inventor: Bingwei LU
  • Small molecule compound
    Patent number: 11912669
    Abstract: The present invention relates to compositions and methods for the treatment of cancer and other diseases associated with mitochondrial dysfunction, including but not limited to, neurodegenerative disease, brain injuries, and certain non-neurological disorders, using a novel compound, 6-chloro-3-(2,4-dichloro-5-methoxyphenyl)-2-mercapto-7-methoxyquinazolin-4(3H)-one, and derivatives thereof.
    Type: Grant
    Filed: November 29, 2021
    Date of Patent: February 27, 2024
    Assignee: Cerepeut, Inc.
    Inventor: Bingwei Lu
  • Small molecule compound
    Patent number: 11186550
    Abstract: The present invention relates to compositions and methods for the treatment of cancer and other diseases associated with mitochondrial dysfunction, including but not limited to, neurodegenerative disease, brain injuries, and certain non-neurological disorders, using a novel compound CPT-2008 and derivatives thereof.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: November 30, 2021
    Assignee: Cerepeut, Inc.
    Inventor: Bingwei Lu